Condensyl® and decreases sperm DNA damage which is a risk factor for male infertility: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006
Abstract Following an application from Laboratoire Nurilia submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-05-01
|
Series: | EFSA Journal |
Subjects: | |
Online Access: | https://doi.org/10.2903/j.efsa.2017.4775 |
id |
doaj-2716e0a4b22442bca5a064a050ff5ad8 |
---|---|
record_format |
Article |
spelling |
doaj-2716e0a4b22442bca5a064a050ff5ad82021-05-02T05:59:47ZengWileyEFSA Journal1831-47322017-05-01155n/an/a10.2903/j.efsa.2017.4775Condensyl® and decreases sperm DNA damage which is a risk factor for male infertility: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)Dominique TurckJean‐Louis BressonBarbara BurlingameTara DeanSusan Fairweather‐TaitMarina HeinonenKaren Ildico Hirsch‐ErnstInge MangelsdorfHarry J McArdleAndroniki NaskaMonika Neuhäuser‐BertholdGrażyna NowickaKristina PentievaYolanda SanzAnders SjödinMartin SternDaniel ToméHenk Van LoverenMarco VincetiPeter WillattsAmbroise MartinJohn Joseph StrainAlfonso SianiAbstract Following an application from Laboratoire Nurilia submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to ‘Condensyl® and decreases sperm DNA damage. High sperm DNA damage is a risk factor for male subfertility/infertility'. Condensyl® is a fixed combination of opuntia fruit dry extract, N‐acetyl cysteine, zinc, nicotinamide, vitamins B2, B6, B12 and E, and folic acid. The Panel considers that Condensyl® is sufficiently characterised. The Panel assumes that the disease that is the subject of the application is male infertility and that the target population for the claim includes males wishing to increase their fertility but excludes males with clinical infertility. The Panel considers that the reduction of DNA sperm damage is a beneficial physiological effect in the context of reducing the risk of male infertility. The applicant provided four human intervention studies conducted in males with clinical infertility, from which no conclusions could be drawn for the scientific substantiation of the claim. The Panel concludes that a cause and effect relationship has not been established between the consumption of Condensyl® and reduction of DNA sperm damage in the context of reducing the risk of male infertility.https://doi.org/10.2903/j.efsa.2017.4775Condensyl®fertilitysperm DNAhealth claim |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Dominique Turck Jean‐Louis Bresson Barbara Burlingame Tara Dean Susan Fairweather‐Tait Marina Heinonen Karen Ildico Hirsch‐Ernst Inge Mangelsdorf Harry J McArdle Androniki Naska Monika Neuhäuser‐Berthold Grażyna Nowicka Kristina Pentieva Yolanda Sanz Anders Sjödin Martin Stern Daniel Tomé Henk Van Loveren Marco Vinceti Peter Willatts Ambroise Martin John Joseph Strain Alfonso Siani |
spellingShingle |
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Dominique Turck Jean‐Louis Bresson Barbara Burlingame Tara Dean Susan Fairweather‐Tait Marina Heinonen Karen Ildico Hirsch‐Ernst Inge Mangelsdorf Harry J McArdle Androniki Naska Monika Neuhäuser‐Berthold Grażyna Nowicka Kristina Pentieva Yolanda Sanz Anders Sjödin Martin Stern Daniel Tomé Henk Van Loveren Marco Vinceti Peter Willatts Ambroise Martin John Joseph Strain Alfonso Siani Condensyl® and decreases sperm DNA damage which is a risk factor for male infertility: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 EFSA Journal Condensyl® fertility sperm DNA health claim |
author_facet |
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Dominique Turck Jean‐Louis Bresson Barbara Burlingame Tara Dean Susan Fairweather‐Tait Marina Heinonen Karen Ildico Hirsch‐Ernst Inge Mangelsdorf Harry J McArdle Androniki Naska Monika Neuhäuser‐Berthold Grażyna Nowicka Kristina Pentieva Yolanda Sanz Anders Sjödin Martin Stern Daniel Tomé Henk Van Loveren Marco Vinceti Peter Willatts Ambroise Martin John Joseph Strain Alfonso Siani |
author_sort |
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) |
title |
Condensyl® and decreases sperm DNA damage which is a risk factor for male infertility: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 |
title_short |
Condensyl® and decreases sperm DNA damage which is a risk factor for male infertility: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 |
title_full |
Condensyl® and decreases sperm DNA damage which is a risk factor for male infertility: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 |
title_fullStr |
Condensyl® and decreases sperm DNA damage which is a risk factor for male infertility: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 |
title_full_unstemmed |
Condensyl® and decreases sperm DNA damage which is a risk factor for male infertility: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 |
title_sort |
condensyl® and decreases sperm dna damage which is a risk factor for male infertility: evaluation of a health claim pursuant to article 14 of regulation (ec) no 1924/2006 |
publisher |
Wiley |
series |
EFSA Journal |
issn |
1831-4732 |
publishDate |
2017-05-01 |
description |
Abstract Following an application from Laboratoire Nurilia submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to ‘Condensyl® and decreases sperm DNA damage. High sperm DNA damage is a risk factor for male subfertility/infertility'. Condensyl® is a fixed combination of opuntia fruit dry extract, N‐acetyl cysteine, zinc, nicotinamide, vitamins B2, B6, B12 and E, and folic acid. The Panel considers that Condensyl® is sufficiently characterised. The Panel assumes that the disease that is the subject of the application is male infertility and that the target population for the claim includes males wishing to increase their fertility but excludes males with clinical infertility. The Panel considers that the reduction of DNA sperm damage is a beneficial physiological effect in the context of reducing the risk of male infertility. The applicant provided four human intervention studies conducted in males with clinical infertility, from which no conclusions could be drawn for the scientific substantiation of the claim. The Panel concludes that a cause and effect relationship has not been established between the consumption of Condensyl® and reduction of DNA sperm damage in the context of reducing the risk of male infertility. |
topic |
Condensyl® fertility sperm DNA health claim |
url |
https://doi.org/10.2903/j.efsa.2017.4775 |
work_keys_str_mv |
AT efsapanelondieteticproductsnutritionandallergiesnda condensylanddecreasesspermdnadamagewhichisariskfactorformaleinfertilityevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT dominiqueturck condensylanddecreasesspermdnadamagewhichisariskfactorformaleinfertilityevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT jeanlouisbresson condensylanddecreasesspermdnadamagewhichisariskfactorformaleinfertilityevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT barbaraburlingame condensylanddecreasesspermdnadamagewhichisariskfactorformaleinfertilityevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT taradean condensylanddecreasesspermdnadamagewhichisariskfactorformaleinfertilityevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT susanfairweathertait condensylanddecreasesspermdnadamagewhichisariskfactorformaleinfertilityevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT marinaheinonen condensylanddecreasesspermdnadamagewhichisariskfactorformaleinfertilityevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT karenildicohirschernst condensylanddecreasesspermdnadamagewhichisariskfactorformaleinfertilityevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT ingemangelsdorf condensylanddecreasesspermdnadamagewhichisariskfactorformaleinfertilityevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT harryjmcardle condensylanddecreasesspermdnadamagewhichisariskfactorformaleinfertilityevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT andronikinaska condensylanddecreasesspermdnadamagewhichisariskfactorformaleinfertilityevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT monikaneuhauserberthold condensylanddecreasesspermdnadamagewhichisariskfactorformaleinfertilityevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT grazynanowicka condensylanddecreasesspermdnadamagewhichisariskfactorformaleinfertilityevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT kristinapentieva condensylanddecreasesspermdnadamagewhichisariskfactorformaleinfertilityevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT yolandasanz condensylanddecreasesspermdnadamagewhichisariskfactorformaleinfertilityevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT anderssjodin condensylanddecreasesspermdnadamagewhichisariskfactorformaleinfertilityevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT martinstern condensylanddecreasesspermdnadamagewhichisariskfactorformaleinfertilityevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT danieltome condensylanddecreasesspermdnadamagewhichisariskfactorformaleinfertilityevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT henkvanloveren condensylanddecreasesspermdnadamagewhichisariskfactorformaleinfertilityevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT marcovinceti condensylanddecreasesspermdnadamagewhichisariskfactorformaleinfertilityevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT peterwillatts condensylanddecreasesspermdnadamagewhichisariskfactorformaleinfertilityevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT ambroisemartin condensylanddecreasesspermdnadamagewhichisariskfactorformaleinfertilityevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT johnjosephstrain condensylanddecreasesspermdnadamagewhichisariskfactorformaleinfertilityevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT alfonsosiani condensylanddecreasesspermdnadamagewhichisariskfactorformaleinfertilityevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 |
_version_ |
1721494515705970688 |